CinCor Pharma picks up $50 mln Series A
CinCor Pharma, a biopharmaceutical company, has secured $50 million in Series A funding. Sofinnova Investments led the round.
14 May 2019•1 min read
CinCor Pharma, a biopharmaceutical company, has secured $50 million in Series A funding. Sofinnova Investments led the round.
